Suvorexant, 10 mg

Suvorexant is characterized by a well-defined molecular structure, identified as an imidazopyridine derivative. Its molecular formula is C18H19FNO3, with a molecular weight of 313.33 g/mol. This compound serves as an orexin receptor antagonist, playing a key role in sleep regulation. It is available in a pure form, with a specified purity of 99%. The compound comes in a pack containing 10 mg tablets, making it suitable for targeted dosage administration. Additionally, suvorexant demonstrates selectivity for orexin receptors, contributing to its efficacy in treating insomnia disorders.

• CAS Number: 1030377-33-3